Skip to main content
editor@theusajournals.com | Oscar Publishing Services Journal Home
Login

International Journal of Medical Sciences And Clinical Research

Peer Reviewed | Open Access | E-ISSN: 2771-2265
Published Article

Hormonal and Psychoemotional Status in Uterine Fibroids: Neuroendocrine Mechanisms, Stress Responses, And Changes in Parameters Before and After Surgical Intervention

Hormonal and Psychoemotional Status in Uterine Fibroids: Neuroendocrine Mechanisms, Stress Responses, And Changes in Parameters Before and After Surgical Intervention

Authors

  • Najmutdinova Dilbar Kamariddinovna
    Head of the Department of Obstetrics and Gynecology, Doctor of Medical Sciences, Professor, Tashkent State Medical University, Tashkent, Uzbekistan
  • Kayumova Dilrabo Tolmasovna
    Professor of the Department of Obstetrics and Gynecology, Doctor of Medical Sciences, Tashkent State Medical University, Tashkent, Uzbekistan
  • Kobiljonova Madina Ulugbek qizi
    Master’s student, Department of Obstetrics and Gynecology, Tashkent State Medical University, Tashkent, Uzbekistan

DOI:

https://doi.org/10.37547/ijmscr/Volume06Issue05-23

Keywords:

Uterine fibroids leiomyoma hormonal status

Abstract

Current concepts of the pathogenesis of uterine fibroids emphasize the leading role of estrogens and progesterone, local receptor sensitivity of myomatous tissue, growth factors, the extracellular matrix, oxidative stress, and neuroendocrine mechanisms. At the same time, the clinical course of the disease is often accompanied by chronic pelvic pain, heavy menstrual bleeding, anemia, impaired reproductive plans, and reduced sexual and social functioning, which intensify anxiety, depressive manifestations, and the overall stress burden.

The aim of this review is to analyze contemporary international data on the hormonal and psychoemotional status of women with uterine fibroids, with an emphasis on neuroendocrine mechanisms, stress responses, and the dynamics of indicators before and after surgical intervention. The article considers the key pathogenetic links of uterine fibroids, the role of the hypothalamic-pituitary-ovarian and hypothalamic-pituitary-adrenal systems, the influence of chronic stress on hormonal status, the significance of anxiety and depression in the clinical course of the disease, as well as changes in psychoemotional status after myomectomy and hysterectomy. The review highlights the need for a comprehensive assessment of patients with uterine fibroids, including not only ultrasound, clinical gynecological, and hormonal parameters, but also psychoemotional status, stress level, quality of life, and adaptive potential.

References

Al-amer R., Ramjan L., Glew P., Darwish M. Prevalence and predictors of anxiety and stress among women undergoing hysterectomy: a cross-sectional study. BMC Women’s Health. 2025;25:124. doi:10.1186/s12905-025-03657-8.

Bulun S.E., Yin P., Wei J.J., et al. Uterine fibroids. Physiological Reviews. 2025;105(4):1947–1988. doi:10.1152/physrev.00010.2024.

Chiuve S.E., Huisingh C., Marsh E.E., Wise L.A., et al. Uterine fibroids and incidence of depression, anxiety and self-directed violence: a cohort study. Journal of Epidemiology and Community Health. 2022;76(1):92–99. doi:10.1136/jech-2020-214565.

de Lange M.E., Semmler A., Mol B.W.J., Bet P.M., Huirne J.A.F., Hehenkamp W.J.K. Considerations on implementation of the newest treatment for symptomatic uterine fibroids: oral GnRH antagonists. British Journal of Clinical Pharmacology. 2024;90(2):392–405. doi:10.1111/bcp.15897.

Ferhi M., Abdessalem S., Bouaziz M., et al. Psychological outcomes and quality of life after hysterectomy for benign diseases: a prospective cohort study. Cureus. 2024;16(5). doi:10.7759/cureus.60137.

Guo Y., Zhang X., Li H., et al. Explanation of chronic stressors in older women with uterine fibroids: a qualitative study. Frontiers in Public Health. 2025;13:1652346. doi:10.3389/fpubh.2025.1652346.

Han X., Zhang Y., Liu J., et al. Psychological distress and uterine fibroids: a bidirectional two-sample Mendelian randomization study. BMC Women’s Health. 2024;24:351. doi:10.1186/s12905-024-03188-8.

Martín M.J.S., García M., Pérez-López F.R. Efficacy of GnRH antagonists in the treatment of uterine fibroids: a systematic review. Medicina. 2025;61(3):412. doi:10.3390/medicina61030412.

Munro M.G., Tchaikovski S.N., Murji A. The epidemiology and pathogenesis of uterine fibroids. International Journal of Gynecology & Obstetrics. 2025;171(3):1029–1045. doi:10.1002/ijgo.70527.

Neumann B., Singh B., Brennan J., Blanck J., Segars J.H. The impact of fibroid treatments on quality of life and mental health: a systematic review. Fertility and Sterility. 2024;121(3):400–425. doi:10.1016/j.fertnstert.2024.01.021.

Niaz R., Saeed M., Khan H., Ali M.A., Irshad A.H., Faiz M., et al. Efficacy and safety of oral GnRH antagonists in patients with uterine fibroids: a systematic review. Journal of Obstetrics and Gynaecology Canada. 2022;44(12):1279–1288. doi:10.1016/j.jogc.2022.10.012.

Stewart E.A., Laughlin-Tommaso S.K., Catherino W.H., Lalitkumar S., Gupta D., Vollenhoven B. Uterine fibroids. Nature Reviews Disease Primers. 2016; 2:16043. doi:10.1038/nrdp.2016.43.

Wallace K., Stewart E.A., Wise L.A., Nicholson W.K., Parry J.P., Zhang S., et al. Anxiety, depression, and quality of life after procedural intervention for uterine fibroids. Journal of Women’s Health. 2022;31(3):415–424. doi:10.1089/jwh.2020.8915.

Wang S., Li Y., Chen X., et al. The estrogen-progestogen-oxidative stress network in uterine fibroids: mechanisms and therapeutic implications. Free Radical Research. 2026. doi:10.1080/10715762.2026.2622747.

Yang Q., Ciebiera M., Bariani M.V., Ali M., Elkafas H., Boyer T.G., Al-Hendy A. Comprehensive review of uterine fibroids: developmental origin, pathogenesis, and treatment. Endocrine Reviews. 2022;43(4):678–719. doi:10.1210/endrev/bnab039.